Neuland Labs.

Market Cap: Mid Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE794A01010
NSEID: NEULANDLAB
BSEID: 524558

INR

11,690.80

790.75 (7.25%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 41.64 k

{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "11,690.80",
    "chg": 790.75,
    "chgp": "7.25%",
    "dir": 1,
    "prev_price": "10,900.05",
    "mcapval": "14,999.17 Cr",
    "mcap": "Mid Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE794A01010",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:06 AM",
    "bse_nse_vol": "41.64 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Neuland Laboratories Outperforms Sector Amid High Volatility and Positive Trend Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-gains-6-56-outperforming-pharmaceuticals-sector-on-april-3-2025-1693205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/NeulandLaborato_priceRelatedfactors_882918.png",
        "date": "2025-04-03 09:30:19",
        "description": "Neuland Laboratories has demonstrated strong performance, gaining 6.56% on April 3, 2025, significantly outperforming its sector. The stock reached an intraday high of Rs 12,203.45 and has shown a cumulative return of 6.36% over two days. Its annual increase stands at 89.93%, far exceeding the Sensex's growth."
      },
      {
        "title": "Neuland Laboratories Shows Resilience Amid Mixed Technical Indicators and Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-technical-trend-shifts-from-sideways-to-mildly-bearish-amid-mixed-signals-1692174",
        "imagepath": "",
        "date": "2025-04-03 08:00:51",
        "description": "Neuland Laboratories, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 11,495.00, showing a slight increase from the previous close of 11,473.50. Over the past week, Neuland has demonstrated a stock return of 2.14%, contrasting with a decline of 0.87% in the Sensex, indicating a positive short-term performance relative to the broader market.\n\nIn terms of technical indicators, the weekly MACD and KST are showing bearish signals, while the monthly metrics indicate a mildly bearish trend. The Relative Strength Index (RSI) presents a bullish signal on a weekly basis, but no clear signal is evident on a monthly scale. Additionally, the Bollinger Bands reflect a bearish stance weekly, while monthly trends suggest a mildly bullish outlook.\n\nNeuland's performance over various time frames high..."
      },
      {
        "title": "Neuland Laboratories Exhibits Mixed Stock Performance Amidst Strong Long-Term Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-stock-surges-77-88-over-past-year-outperforming-sensex-1682387",
        "imagepath": "",
        "date": "2025-04-02 18:00:13",
        "description": "Neuland Laboratories, a mid-cap player in the Pharmaceuticals & Drugs industry, has shown notable stock activity today. With a market capitalization of Rs 14,677.00 crore, the company has a price-to-earnings (P/E) ratio of 61.46, significantly higher than the industry average of 34.70. \n\nOver the past year, Neuland Laboratories has delivered an impressive performance, gaining 77.88%, while the Sensex has only increased by 3.67%. In the short term, the stock has seen a modest rise of 0.19% today, compared to the Sensex's 0.78% increase. Over the past week, Neuland's stock has risen by 2.14%, contrasting with a decline of 0.87% in the Sensex.\n\nHowever, the three-month performance indicates a decline of 19.49%, while the year-to-date performance shows a decrease of 16.55%. In longer-term metrics, Neuland Laboratories has excelled, with a staggering 957.94% increase over three years and an extraordinary 4080.00..."
      },
      {
        "title": "Neuland Laboratories Faces Mixed Financial Performance Amidst Shift in Technical Outlook",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-stock-downgraded-to-sell-amid-declining-profits-and-technical-shift-1670594",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/NeulandLaborato_mojoScore_861554.png",
        "date": "2025-04-02 08:07:17",
        "description": "Neuland Laboratories has recently experienced a change in its technical outlook, shifting to a sideways trend. While the company shows strong debt servicing capabilities, recent quarterly results indicate a decline in profitability. Nevertheless, it maintains a solid long-term growth trajectory and has significant institutional investor confidence."
      },
      {
        "title": "Neuland Laboratories Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-technical-trend-shifts-from-mildly-bullish-to-sideways-amid-price-decline-1670315",
        "imagepath": "",
        "date": "2025-04-02 08:01:43",
        "description": "Neuland Laboratories, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 11,473.50, down from a previous close of 12,076.95, with a notable 52-week high of 18,089.55 and a low of 5,557.00. Today's trading saw a high of 11,980.15 and a low of 11,334.15.\n\nThe technical summary indicates a mixed performance across various indicators. The MACD shows bearish signals on a weekly basis and mildly bearish on a monthly basis, while the RSI presents a bullish stance weekly, with no signal monthly. Bollinger Bands reflect a bearish trend weekly but mildly bullish monthly. Daily moving averages suggest a mildly bullish outlook, whereas the KST indicates bearish trends for both weekly and monthly assessments. Notably, Dow Theory and On-Balance Volume show no discernible trends.\n\nIn terms of return..."
      },
      {
        "title": "Neuland Laboratories Faces Market Sentiment Shift Amid Mixed Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-stock-declines-5-25-amid-broader-market-downturn-1661748",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/NeulandLaborato_priceRelatedfactors_853935.png",
        "date": "2025-04-01 12:00:19",
        "description": "Neuland Laboratories saw a significant decline on April 1, 2025, reversing gains from the previous days and underperforming against the broader market. Despite recent volatility, the stock has shown strong performance over the past year, significantly outpacing the Sensex, while experiencing a notable decline over the last three months."
      },
      {
        "title": "Neuland Laboratories Outperforms Market Amid Broader Sensex Decline, Signaling Strong Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-stock-rises-5-09-outperforming-sector-by-5-86-1641739",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NeulandLaborato_priceRelatedfactors_835331.png",
        "date": "2025-03-28 11:30:17",
        "description": "Neuland Laboratories, a midcap pharmaceutical company, experienced notable gains on March 28, 2025, outperforming the broader market despite a decline in the Sensex. The stock has shown a strong upward trend recently, achieving significant returns over various time frames, including a substantial increase over the past year."
      },
      {
        "title": "Neuland Laboratories Shows Strong Short-Term Recovery Amid Mixed Long-Term Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-stock-rises-6-47-outperforming-sensex-by-5-66-1629565",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NeulandLaborato_priceRelatedfactors_828570.png",
        "date": "2025-03-27 15:15:18",
        "description": "Neuland Laboratories saw a significant increase on March 27, 2025, reversing two days of decline and outperforming the broader market. The stock is above its short-term moving averages but below its long-term ones. Over the past three years, it has shown remarkable growth, significantly surpassing the Sensex."
      },
      {
        "title": "Neuland Laboratories Faces Significant Stock Decline Amid Broader Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-stock-declines-5-06-underperforming-against-sector-and-market-trends-1607288",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/NeulandLaborato_priceRelatedfactors_809466.png",
        "date": "2025-03-26 14:15:16",
        "description": "Neuland Laboratories has faced a significant stock decline, dropping 5.06% today and 5.6% over the past two days. The stock is trading below key moving averages, indicating a bearish trend. Year-to-date, it has decreased by 17.97%, despite a remarkable 932.13% increase over the last three years."
      }
    ],
    "total": 199,
    "sid": "229993",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "02-Apr-2025",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2025",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "19-Mar-2025",
      "details": "Intimation about Schedule of Analyst / Institutional Investor Meeting on March 25 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>140%</strong> dividend, ex-date: 12 Jul 24",
          "dt": "2024-07-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Neuland Laboratories Outperforms Sector Amid High Volatility and Positive Trend Indicators

2025-04-03 09:30:19

Neuland Laboratories has demonstrated strong performance, gaining 6.56% on April 3, 2025, significantly outperforming its sector. The stock reached an intraday high of Rs 12,203.45 and has shown a cumulative return of 6.36% over two days. Its annual increase stands at 89.93%, far exceeding the Sensex's growth.

Neuland Laboratories Shows Resilience Amid Mixed Technical Indicators and Market Dynamics

2025-04-03 08:00:51

Neuland Laboratories, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 11,495.00, showing a slight increase from the previous close of 11,473.50. Over the past week, Neuland has demonstrated a stock return of 2.14%, contrasting with a decline of 0.87% in the Sensex, indicating a positive short-term performance relative to the broader market. In terms of technical indicators, the weekly MACD and KST are showing bearish signals, while the monthly metrics indicate a mildly bearish trend. The Relative Strength Index (RSI) presents a bullish signal on a weekly basis, but no clear signal is evident on a monthly scale. Additionally, the Bollinger Bands reflect a bearish stance weekly, while monthly trends suggest a mildly bullish outlook. Neuland's performance over various time frames high...

Neuland Laboratories Exhibits Mixed Stock Performance Amidst Strong Long-Term Gains

2025-04-02 18:00:13

Neuland Laboratories, a mid-cap player in the Pharmaceuticals & Drugs industry, has shown notable stock activity today. With a market capitalization of Rs 14,677.00 crore, the company has a price-to-earnings (P/E) ratio of 61.46, significantly higher than the industry average of 34.70. Over the past year, Neuland Laboratories has delivered an impressive performance, gaining 77.88%, while the Sensex has only increased by 3.67%. In the short term, the stock has seen a modest rise of 0.19% today, compared to the Sensex's 0.78% increase. Over the past week, Neuland's stock has risen by 2.14%, contrasting with a decline of 0.87% in the Sensex. However, the three-month performance indicates a decline of 19.49%, while the year-to-date performance shows a decrease of 16.55%. In longer-term metrics, Neuland Laboratories has excelled, with a staggering 957.94% increase over three years and an extraordinary 4080.00...

Neuland Laboratories Faces Mixed Financial Performance Amidst Shift in Technical Outlook

2025-04-02 08:07:17

Neuland Laboratories has recently experienced a change in its technical outlook, shifting to a sideways trend. While the company shows strong debt servicing capabilities, recent quarterly results indicate a decline in profitability. Nevertheless, it maintains a solid long-term growth trajectory and has significant institutional investor confidence.

Neuland Laboratories Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-04-02 08:01:43

Neuland Laboratories, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 11,473.50, down from a previous close of 12,076.95, with a notable 52-week high of 18,089.55 and a low of 5,557.00. Today's trading saw a high of 11,980.15 and a low of 11,334.15. The technical summary indicates a mixed performance across various indicators. The MACD shows bearish signals on a weekly basis and mildly bearish on a monthly basis, while the RSI presents a bullish stance weekly, with no signal monthly. Bollinger Bands reflect a bearish trend weekly but mildly bullish monthly. Daily moving averages suggest a mildly bullish outlook, whereas the KST indicates bearish trends for both weekly and monthly assessments. Notably, Dow Theory and On-Balance Volume show no discernible trends. In terms of return...

Neuland Laboratories Faces Market Sentiment Shift Amid Mixed Performance Metrics

2025-04-01 12:00:19

Neuland Laboratories saw a significant decline on April 1, 2025, reversing gains from the previous days and underperforming against the broader market. Despite recent volatility, the stock has shown strong performance over the past year, significantly outpacing the Sensex, while experiencing a notable decline over the last three months.

Neuland Laboratories Outperforms Market Amid Broader Sensex Decline, Signaling Strong Momentum

2025-03-28 11:30:17

Neuland Laboratories, a midcap pharmaceutical company, experienced notable gains on March 28, 2025, outperforming the broader market despite a decline in the Sensex. The stock has shown a strong upward trend recently, achieving significant returns over various time frames, including a substantial increase over the past year.

Neuland Laboratories Shows Strong Short-Term Recovery Amid Mixed Long-Term Trends

2025-03-27 15:15:18

Neuland Laboratories saw a significant increase on March 27, 2025, reversing two days of decline and outperforming the broader market. The stock is above its short-term moving averages but below its long-term ones. Over the past three years, it has shown remarkable growth, significantly surpassing the Sensex.

Neuland Laboratories Faces Significant Stock Decline Amid Broader Market Challenges

2025-03-26 14:15:16

Neuland Laboratories has faced a significant stock decline, dropping 5.06% today and 5.6% over the past two days. The stock is trading below key moving averages, indicating a bearish trend. Year-to-date, it has decreased by 17.97%, despite a remarkable 932.13% increase over the last three years.